Radiopharm Theranostics Ltd SEC filings RADX
Radiopharm Theranostics Ltd has 163 filings in SEC EDGAR's recent list, going back to Dec 16, 2022. Its latest annual report, Form 20-F, was filed on Sep 30, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 23, 2026 | — |
| EFFECT | Filing | Dec 23, 2025 | — |
| EFFECT | Filing | Dec 23, 2025 | — |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| EFFECT | Filing | Dec 13, 2024 | — |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2024 | — |
| SEC STAFF LETTER | Filing | Dec 3, 2024 | — |
| SEC STAFF ACTION | Filing | Nov 27, 2024 | — |
| CERT | Filing | Nov 25, 2024 | — |
| CORRESP | Letter to the SEC | Nov 25, 2024 | — |
| 20FR12B/A | Amendment no. 7 to form 20fr12b | Nov 12, 2024 | — |
| CORRESP | Letter to the SEC | Nov 5, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2024 | — |
| 20FR12B/A | Amendment no. 6 to form 20fr12b | Oct 21, 2024 | — |
| CORRESP | Letter to the SEC | Sep 25, 2024 | — |
| 20FR12B/A | Amendment no. 5 to form 20fr12b | Sep 25, 2024 | — |
| EFFECT | Filing | Sep 18, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2024 | — |
| CORRESP | Letter to the SEC | Sep 9, 2024 | — |
| 20FR12B/A | Amendment no. 4 to form 20fr12b | Sep 9, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2024 | — |
| 20FR12B/A | Amendment no. 3 to form 20fr12b | Jul 25, 2024 | — |
| CORRESP | Letter to the SEC | Apr 14, 2023 | — |
| 20FR12B/A | Amendment no. 2 to form 20fr12b | Apr 14, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2023 | — |
| CORRESP | Letter to the SEC | Mar 20, 2023 | — |
| 20FR12B/A | Amendment no. 1 to form 20fr12b | Mar 20, 2023 | — |
| SEC STAFF LETTER | Filing | Mar 6, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2023 | — |
| CORRESP | Letter to the SEC | Feb 13, 2023 | — |
| 20FR12B | Registration statement | Feb 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2023 | — |
| DRS | Filing | Dec 16, 2022 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RADX (Nasdaq), RDPTF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Carlton Vic
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1949257
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.